General procedure for the preparation of 4 and 5
(CH N), 53.43 (OCH ), 61.78 (CH CH ), 62.71 (CH CH ),
2
3
3
2
3
2
72.79 (q, 2J \ 29.7, CCF ), 122.21 (CH CH2C), 128.43 (q,
CF
3
2
A solution of 3 (3 mmol) in dry DMF (9 ml) was added to a
suspension of NaH (6 mmol) in dry DMF (15 ml) at 0 ¡C. The
mixture was stirred at room temperature for 0.5 h and then 9
mmol of allyl bromide (in solution in 6 ml of DMF) were
added. After stirring for an additional 5 h, the mixture was
hydrolyzed with water (20 ml) and extracted with diethyl ether
(2 ] 20 ml). The organic layer was washed with water (4 ] 20
1J \ 285.5 Hz, CF ), 127.26, 129.15, 133.33 (aromatic CH),
CF
3
133.83
[CH C(CO)2C],
[CHC(CO)2C], 165.70 (quat. CH2C), 164.87, 166.39, 167.21
(C2O).
135.60
(ipso
C),
139.85
2
11. 1H NMR (CDCl , 200.132 MHz): d 1.33 (t, 3 H,
3
3J \ 7.1, CH CH ), 1.34 (t, 3 H, 3J \ 7.1, CH CH ), 3.83 (s, 3
3
2
3
2
ml), dried over MgSO and Ðltered. The solvent was removed
H, OCH ), 4.34 (q, 2 H, 3J \ 7.1, CH CH ), 4.35 (q, 2 H,
4
3
3
2
under reduced pressure and the crude product was puriÐed by
3J \ 7.1, CH CH ), 4.69 (d, 1 H, 2J \ 14.4, CH N), 5.18 (d, 1
3
2
2
2
Ñash chromatography (diethyl etherÈpentane). Compounds
4a–e and 5 were characterized by 1H, 13C and 19F NMR and
gave satisfactory elemental analyses.
H, 2J \ 14.4, CH N), 7.44È7.61 (m, 4 H, aromatic H), 7.71 (d,
1 H, 3J \ 7.71 Hz, aromatic H), 7.88È7.98 (m, 2 H, aromatic
H). 19F NMR (CDCl , 282.408 MHz): d [72.51 (s, 3 F, CF ).
3
3
13C NMR (CDCl , 50.329 MHz): d 14.04 (CH CH ), 14.12
4a. 1H NMR (CDCl , 200.132 MHz): d 2.75 (s, 1 H,
3
3
2
(CH CH ), 53.78 (OCH ), 54.48 (CH N), 62.20 (CH CH ),
3
C3 CH), 3.97 (s, 3 H, OCH ), 4.00È4.27 (m, 2 H, CH N), 4.87
3
2
3
2
3
2
62.32 (CH CH ), 72.95 (CCF ), 126.02, 127.47, 129.23, 133.32,
3
2
(dm, 1 H, 3J \ 10.1, cis-CH 2CH), 4.94 (dm, 1 H, 3J \ 16.9
Hz, trans-CH 2CH), 5.52È5.74 (m, 1 H, CH 2CH), 7.44È7.65
3
2
3
133.50 (aromatic C), 128.6, 134.77 (quat. aromatic C, CC2O),
132.7 (q, 1J \ 283.0 Hz, CF ), 128.60, 136.60, 138.53, 139.22
(quat. aromatic C), 165.44, 165.72, 166.61 (C2O).
2
2
2
(m, 3 H, Ph), 7.88È7.97 (m, 2 H, Ph). 19F NMR (CDCl ,
CF
3
3
3
188.292 MHz): d [71.9 (s, 3 F, CF ). 13C NMR (CDCl ,
3
50.329 MHz): d 50.60 (NCH ), 54.35 (OCH ), 72.59 (quat. C),
2
3
2
Acknowledgements
The authors wish to thank the European Union INTAS pro-
gramme 97-1874 for support, the COST programme D12/
0025/99 and the Region Bretagne for a grant to J. LN.
80.15 (C3 CH), 97.95 (C3 CH), 117.44 (CH 2CH), 122.39 (q,
1J \ 288.7 Hz, CF ), 128.65, 128.99, 133.60 (aromatic CH),
133.48 (CH 2CH), 139.22 (ipso C), 163.294 (C2O). Anal.
found: C, 49.29; H, 3.68%. Calc. for C
CF
3
2
H
F NO S: C,
15 14 3
4
49.86; H, 3.90%.
References
5. 1H NMR (CDCl , 200.132 MHz): d 1.39 (s, 9 H, 3
3
1
For a review see: H. Heimgartner, Angew. Chem., Int. Ed. Engl.,
] CH Boc), 2.72 (s, 1 H, C3 CH), 3.83 (s, 3 H, OCH ), 4.10È
3
3
1991, 30, 238.
4.25 (m, 2 H, CH N), 5.13 (dm, 1 H, 3J \ 10.2, cis-CH 2CH),
2
C. Tomiolo, M. Crisma, S. Pegorato, E. L. Becker, S. Polinelli,
W. H. J. Boesten, H. E. Schoemaker, E. M. Meijer, J. Kamphuis
and R. Freer, Peptide Res., 1991, 4, 66.
2
2
5.25 (dm, 1 H, 3J \ 17.2 Hz, trans-CH 2CH), 5.76È6.04 (m, 1
2
H, CH 2CH). 13C NMR (CDCl , 50.329 MHz): d 28.00 (3
2
3
3
] CH Boc), 50.22 (NCH ), 53.45 (OCH ), 73.93 (quat.
3
4
C. Walsh, T etrahedron, 1982, 38, 871 and references cited therein.
(a) Y. Kuroda, M. Okuhara, T. Goto, E. Iguchi, M. Kohsaka, H.
Aoki and H. Imanaka, J. Antibiot., 1980, 33, 125; (b) D. Schirlin,
J. B. Ducep, S. Baltzer, P. Bey, F. Piriou, J. Wagner, J. M. Horn-
sperger, J. G. Heydt, M. J. Jung, C. Danzig, R. Weiss, J. Fischer,
A. Mitschler and A. De Cian, J. Chem. Soc., Perkin T rans. 1,
1992, 1053.
2
3
CCF Cl), 79.14 (C3 CH), 82.45 [C(CH ) ], 97.86 (C3 CH),
2
3 3
116.19 (CH 2CH), 128.06 (t, 1J \ 288.6 Hz, CF Cl), 134.25
(CH 2CH), 152.58 (C2O Boc), 163.23 (C2O).
2
CF
2
2
General procedure for the preparation of 6–9
5
(a) D. J. Barlow and J. M. Thornton, J. Mol. Biol., 1988, 201, 601;
(b) A. M. Koskinen and H. Rapoport, J. Org. Chem., 1989, 54,
1859; (c) H. H. Ibrahim and W. D. Lubell, J. Org. Chem., 1993,
58, 6438.
(a) D. O. Gray and L. Fowden, Nature (L ondon), 1962, 193, 1285;
(b) D. O. Gray and L. Fowden, Phytochemistry, 1972, 11, 745.
F. Manfre, J.-M. Kern and J.-F. Biellmann, J. Org. Chem., 1992,
57, 2060.
M. Picquet, C. Bruneau and P. H. Dixneuf, Chem. Commun.,
1998, 2249.
A mixture of enyne 4 or 5 (1 mmol) and catalyst A or B (5 or
10 mol.%) in toluene was irradiated at room temperature for
0.5 h and then heated at 80 ¡C. The solvent was removed in
vaccum and the crude product was puriÐed by Ñash chroma-
tography (diethyl etherÈpentane). Compounds 6–9 were char-
acterized by 1H, 13C and 19F NMR and gave satisfactory
elemental analyses.
6
7
8
9
6. 1H NMR (CDCl , 200.132 MHz): d 3.87 (s, 3 H, OCH ),
N. Sewald and K. Burger, in Fluorine-containing Amino Acids:
Synthesis and Properties, ed. V. P. Kukhar and V. A. Soloshonok,
Wiley, Chichester, UK, 1995, p. 139, and references cited therein.
3
3
4.03 (d, 1 H, 3J \ 14.8, CH N), 4.53 (d, 1 H, 3J \ 14.8,
2
CH N), 5.21 (d, 1 H, 3J \ 11.4, cis-CH 2CH), 5.47 (d, 1 H,
2
2
3J \ 17.6, trans-CH 2CH), 6.12 (dd, 1 H, 3J \ 11.4, 3J \ 17.7
10 I. L. Knunyants, V. V. Shokina and V. V. Tyuleneva, Dokl. Akad.
Nauk SSSR, 1966, 169, 594; I. L. Knunyants, V. V. Shokina and
V. V. Tyuleneva, Chem. Abs., 1966, 65, 15218e.
11 (a) S. N. Osipov, N. D. Chkanikov, A. F. Kolomiets and A. V.
Fokin, Bull. Acad. Sci. USSR, Div. Chem. Sci. (Engl. T ransl.),
1986, 1256; (b) K. Burger, E. Hoess, K. Gaa, N. Sewald and C.
Schierlinger, Z. Naturforsch. B, 1991, 46, 361; (c) S. N. Osipov
and K. Burger, T etrahedron L ett., 2000, 41, 5659.
12 The protocol described for analogous compounds in K. Burger
and N. Sewald, Synthesis, 1990, 115 was used.
13 S. N. Osipov, A. S. Golubev, N. Sewald, T. Michel, A. F. Kolo-
miets, A. V. Folkin and K. Burger, J. Org. Chem., 1996, 61, 7521.
14 A. Furstner, M. Picquet, C. Bruneau and P. H. Dixneuf, Chem.
Commun., 1998, 1315.
2
Hz, CH 2CH), 6.19È6.27 (m, 1 H, CH CH2C), 7.43È7.65 (m, 3
2
2
H, Ph), 7.82È7.93 (m, 2 H, Ph). 19F NMR (CDCl , 188.292
3
MHz): d [71.9 (s, 3 F, CF ). 13C NMR (CDCl , 50.329
3
3
3
MHz): d 53.53 (OCH ), 55.02 (CH N), 68.02 (CCF ), 119.16
3
2
(CH 2CH), 123.40 (q, 1J \ 287.4 Hz, CF ), 126.71
CF
(CH CH2), 128.58 (CH 2CH), 127.40, 129.07, 133.22 (aromatic
2
2
3
2
CH), 135.40 (quat. C2), 139.51 (ipso C), 165.65 (C2O). Anal
found: C, 49.71; H, 4.17%. Calc. for C
49.86; H, 3.90%.
H
F NO S: C,
15 14 3
4
Characterization of 10 and 11
15 A. Furstner, M. Liebl, C. W. Lehmann, M. Picquet, R. Kunz, C.
Bruneau, D. Touchard and P. H. Dixneuf, Chem. Eur. J., 2000, 6,
1847.
10 (major diastereoisomer). 1H NMR (CDCl , 200.132
3
MHz): d 1.25 (t, 3 H, 3J \ 7.1, CH CH ), 1.29 (t, 3 H,
3
2
3J \ 7.1 Hz, CH CH ), 3.06È3.20 (m, 1 H, 2CHCH ), 3.50È
16 M. Picquet, D. Touchard, C. Bruneau and P. H. Dixneuf, New J.
3
2
2
Chem., 1999, 23, 141.
3.64 (m, 1 H, 2CHCH ), 3.84 (m, 3 H, CH N and CHCH N),
5.88 (m, 1 H, CH CH2), 7.40È7.62 (m, 3 H, Ph), 7.79È7.91 (m,
2 H, Ph). 19F NMR (CDCl , 282.408 MHz): d [71.62 (s, 3 F,
CF ). 13C NMR (CDCl , 50.329 MHz): d 13.83 (CH CH ),
2
2
2
17 (a) T. J. Katz and T. M. Sivavec, J. Am. Chem. Soc., 1985, 107,
737; (b) T. M. Sivavec, T. J. Katz, M. Y. Chiang and G. X.-Q.
Yang, Organometallics, 1989, 8, 1620.
2
3
18 S. Osipov, C. Bruneau, M. Picquet, A. F. Kolomiets and P. H.
Dixneuf, Chem. Commun., 1998, 2053.
3
3
3
2
14.00 (CH CH ), 29.71 (CH CH2), 38.35 (CHCH N), 52.48
3
2
2
2
18
New J. Chem., 2001, 25, 16È18